Are you looking for more information on Byetta? Visit http://byetta.legalview.com for access to a wide range of services, including a Byetta Attorney, a Byetta Lawfirm, and a Byetta Lawsuit
Type 2 Diabetes Patients Studied in Aspirin Trial For Cardiovascular Disease
Recently a study published in the Journal of the American Medical Association found that type 2 diabetes patients who were treated with low-dose aspirin were found to have no significant decrease of antherosclerotic events, also known as hardening or clotting of the arteries, although those over the age of 65 with heart disease and type 2 diabetes did see a reduction of antherosclerotic incidence.
The American Diabetes Association (ADA) reports that the development of type 2 diabetes means more than just managing insulin levels, but it also requires the management of potential risks such as heart disease, heart failure and stroke. According to the ADA, "people with diabetes must also manage blood pressure and cholesterol and talk to their health provider to learn about other ways to reduce their chance for heart attacks and strokes."
What is Cardiovascular Disease?
Cardiovascular disease occur for many reasons but often leads to heart failure, which occurs when the blood backs up into the pulmonary veins, according to the American Heart Association (AHA). There are an array of disease and conditions related to cardiovascular disease including:
Additionally, there are several signs and symptoms that individuals who have type 2 diabetes should watch for, as they may be developing heart failure related to their diabetes or other heart disease:
Type 2 diabetes is when the body cannot or does not produce enough insulin, also known as blood sugar, in order to provide the body with energy. There are several prescription medications available for treating type 2 diabetes including some of the following:
Commonly these drugs are used to either introduce insulin to the body or to use the body’s natural insulin levels within the body. However, there are an array of type 2 diabetes drug side effects that can occur. Byetta (exenatide), introduced from Amylin Pharmaceuticals and Eli Lilly in 2005, is one such drug that has been associated with serious risks among patients consuming the drug.
Byetta has allegedly been causing pancreatitis among patients. If a patient of Byetta feels they may be developing pancreatic conditions it is important for them to seek medical assistance immediately. It may also be necessary for a patient to contact a pharmaceutical attorney to develop litigation or a Byetta class action lawsuit.
Peter Kent is the best-selling author of 50 books and hundreds of articles for magazines and newspapers. He manages Legalview.com, a website hosting a variety of information on legal issues, including Byetta.
Rate This Article
Add Comments
Send To Friends
Print 
Download as PDF